Overcoming Resistance to CDK4/6 Inhibitors
Over time, people may develop resistance to CDK4/6 inhibitors, which means the drugs stop working. Learn about new strategies being studied in clinical trials to overcome resistance.
What are Placebos and How Are They Used in MBC Clinical Trials?
If you are considering enrolling in a clinical trial, you may be concerned about the possibility of getting a placebo. In cancer clinical trials, placebos are never used alone. Click to learn more.
Non-Treatment Trials: Surveys, Interviews, and Registries
Did you know you can contribute to research by providing your health information, biopsy or other samples, or opinions about a treatment you have received? Read more about these types of trials here.
Researching Ways to Make MBC Treatment Easier to Tolerate
Tolerability is the ability to take a drug without experiencing side effects that cause you to stop taking it or reduce its dose. Click to read how clinical trials are studying ways to make MBC treatment easier to tolerate.
Meet the Clinical Trial Team: The Institutional Review Board
This month, we are highlighting the Institutional Review Board (IRB) that protects the safety and privacy of people in clinical trials.
In Memory of Dr. Susan Love
In July 2023, the breast cancer community lost a valued friend, advocate, surgeon, and researcher. Click to read a tribute to Dr. Susan Love.
The Latest Research on Inflammatory Breast Cancer
Hear from experts about the latest research on inflammatory breast cancer, a rare type of breast cancer.
Meet the Clinical Trial Team: The Clinical Trial Sponsor
This month we are continuing our series by highlighting the trial sponsor that funds the trial and collects and assesses the data.
American Association for Cancer Research (AACR) 2023
The AACR held its 2023 conference from April 14-19, 2023. Read MBC-related reports from the meeting here.
American Society for Clinical Oncology (ASCO) 2023
ASCO 2023 was held June 2-6, 2023. Click for MBC updates from the meeting.